Andreas Maetzel
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Andreas Maetzel
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Biotechnology | 7 | |
| Subsidiary | Pharmaceuticals: Major | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Andreas Maetzel tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Public Communications Contact General Counsel | |
| HERON THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
| TERRASCEND CORP. | Agricultural Commodities/Milling | Director/Board Member Director/Board Member | |
CollaGenex Pharmaceuticals, Inc.
 CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | Pharmaceuticals: Major | General Counsel | |
| Sarcoma Foundation of America | Investment Trusts/Mutual Funds | Founder | |
| London South Bank University | College/University | Undergraduate Degree | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
| VERNALIS | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Bay Way Consultants LLC | Founder | ||
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| University of Copenhagen | College/University | Doctorate Degree | |
| ACORDA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| BLACK DIAMOND THERAPEUTICS, INC. | Biotechnology | Chairman | |
Serenity Pharmaceuticals Corp.
 Serenity Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Serenity Pharmaceuticals Corp. develops products pharmaceuticals that address urinary conditions. The company was founded by Samuel Herschkowitz in 2007 and is headquartered in Milford, PA. | Pharmaceuticals: Major | Chairman | |
| NVN LIQUIDATION, INC. | Pharmaceuticals: Major | Chairman | |
| GlaxoSmithKline Foundation | Chairman | ||
H. Lee Moffitt Cancer Center & Research Institute, Inc.
 H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services H. Lee Moffitt Cancer Center & Research Institute, Inc. provides research & contributions to clinical trials, prevention and cancer control. The firm operates as National Cancer Institute (NCI) Comprehensive Cancer Center. The company was founded by Lee H. Moffitt in 1981 and is headquartered in Tampa, FL. | Miscellaneous Commercial Services | Director/Board Member | |
James B. Hunt, Jr. Institute for Educational Leadership & Poli
 James B. Hunt, Jr. Institute for Educational Leadership & Poli Miscellaneous Commercial ServicesCommercial Services James B. Hunt, Jr. Institute for Educational Leadership & Policy Foundation, Inc. provides public education services. It operates as a strategic catalyst for transforming public education. The company was founded in September 2001 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director/Board Member | |
Viamet Pharmaceuticals, Inc.
 Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Chairman | |
Pharmaceutical Product Development LLC
 Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | Miscellaneous Commercial Services | Director/Board Member | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Chief Operating Officer | |
| MALIN CORPORATION PLC | Biotechnology | Director/Board Member | |
Viamet Pharmaceuticals Corp.
 Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Chairman | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| SYROS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| Ealing Hammersmith & West London College | College/University | Graduate Degree | |
| Wake Forest University | College/University | Undergraduate Degree | |
| UNITED THERAPEUTICS CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Yale School of Medicine | College/University | Graduate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree | |
Triangle Residential Options for Substance Abusers, Inc.
 Triangle Residential Options for Substance Abusers, Inc. Medical/Nursing ServicesHealth Services Triangle Residential Options for Substance Abusers, Inc. provides multi-year residential program. It offers treatment, work-based vocational training, education, and continuing care. The company was founded by Kevin McDonald in 1994 and is headquartered in Durham, NC. | Medical/Nursing Services | Director/Board Member | |
| The Fuqua School of Business | College/University | Masters Business Admin | |
| Princeton University | College/University | Undergraduate Degree | |
| UNC School of Law | College/University | Graduate Degree | |
| University of Tennessee | College/University | Undergraduate Degree | |
| Olin Business School | College/University | Undergraduate Degree | |
| LIQUIDIA CORPORATION | Pharmaceuticals: Major | Investor Relations Contact | |
| Tuck School of Business at Dartmouth | College/University | Masters Business Admin | |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| North Carolina Glaxosmithkline Foundation | Chairman | ||
Tavanta Therapeutics, Inc.
 Tavanta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tavanta Therapeutics, Inc. operates as a clinical-stage pharmaceutical company developing a diverse pipeline of specialty drugs. The company is based in King of Prussia, PA and has subsidiaries in Hungary. Lynne M. Powell has been the CEO of the company since 2019. | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Warwick | College/University | Masters Business Admin | |
| University of East London | College/University | Undergraduate Degree | |
Druggability Technologies Holdings Ltd.
 Druggability Technologies Holdings Ltd. BiotechnologyHealth Technology Druggability Technologies Holdings Ltd., part of DRGT Holdco (Malta) Ltd., is a company headquartered in Dublin, Ireland. The firm develops proprietary drugs. | Biotechnology | Chief Executive Officer |
Statistiche
Distribuzione geografica
| Stati Uniti | 41 |
| Regno Unito | 6 |
| Danimarca | 3 |
| Irlanda | 3 |
| Canada | 2 |
Settori
| Health Technology | 28 |
| Consumer Services | 15 |
| Commercial Services | 4 |
| Process Industries | 2 |
| Miscellaneous | 2 |
Posizioni
| Director/Board Member | 51 |
| Independent Dir/Board Member | 27 |
| Corporate Officer/Principal | 27 |
| Chairman | 24 |
| Chief Executive Officer | 13 |
Contatti più connessi
| Insiders | |
|---|---|
| Robert Alexander Ingram | 43 |
| Craig Collard | 18 |
| Andrew Powell | 16 |
| Peder Jensen | 10 |
| Sanj Patel | 10 |
| Lynne Powell | 8 |
| Ira Duarte | 7 |
| Jinky Ang Rosselli | 6 |
| Jason Adair | 5 |
| Noel Barnard | 4 |
| Brett Fleshman | 3 |
| Charles Gayer | 3 |
- Borsa valori
- Insiders
- Andreas Maetzel
- Connessioni Società
